How Has the Orthopedic Biomaterials Market Size Evolved in Recent Years?
The orthopedic biomaterials market has seen considerable growth due to a variety of factors.
• In recent times, there has been a significant increase in the size of the orthopedic biomaterials market. It is projected to expand from $20.51 billion in 2024 to $22.6 billion in 2025, with a compound annual growth rate (CAGR) of 10.2%.
Factors contributing to the historical growth include technological advancements, increased healthcare spending, an uptick in the abundance of healthcare establishments, and economic development.
What are the Market Size and Expected Growth Rates for the Orthopedic Biomaterials Market?
The orthopedic biomaterials market is expected to maintain its strong growth trajectory in upcoming years.
• Anticipations are high for rapid expansion in the orthopedic biomaterials market size in the coming years, with projections pointing to a value of $33.22 billion in 2029, all thanks to a compound annual growth rate (CAGR) of 10.1%.
The estimated surge in this period can be linked to a rise in obesity and arthritis cases, a fast-growing elderly population, and an uptick in joint replacement surgeries. The period is also likely to witness significant trends such as the production of implants via 3D printing technology, the introduction of novel, innovative products, the development of intelligent biomaterial implants, as well as increased merger and acquisition activities.
What Are The Core Factors Supporting Growth In Orthopedic Biomaterials Market?
The orthopedic biomaterials market is anticipated to be propelled by the growing prevalence of musculoskeletal disorders. Such disorders result in fractures, inflammation, and discomfort in joints, ligaments, and tendons, leading to mobility impairments. The probability of experiencing musculoskeletal conditions tends to grow with age. As an example, data from GOV.UK, a governmental department in the UK, demonstrated that in 2023, 18.4% of the population aged 16 and over reported suffering from a chronic musculoskeletal (MSK) disorder. This represents an increase from the 17.6% prevalence noted in 2022. Consequently, the surge in musculoskeletal issues is expected to boost the orthopedic biomaterials market.
What Are The Key Segments Within The Global Orthopedic Biomaterials Market?
The orthopedic biomaterials market covered in this report is segmented –
1) By Material Type: Ceramics And Bioactive Glasses, Calcium Phosphate Cements, Polymers, Metal, Composites
2) By Application: Orthopedic Implants, Joint Replacement/Reconstruction, Bio-Resorbable Tissue Fixation, Other Applications
3) By End-User: Hospitals, Clinics, Other End-Users
Subsegments:
1) By Ceramics And Bioactive Glasses: Bioactive Glasses, Alumina Ceramics, Zirconia Ceramics
2) By Calcium Phosphate Cements: Hydroxyapatite (HA) Cements, Tricalcium Phosphate (TCP) Cements, Biphasic Calcium Phosphate Cements
3) By Polymers: Polyethylene (PE), Polymethyl Methacrylate (PMMA), Polyetheretherketone (PEEK)
4) By Metal: Titanium Alloys, Stainless Steel, Cobalt-Chromium Alloys
5) By Composites: Fiber-Reinforced Composites, Polymer-Ceramic Composites, Metal-Ceramic Composites
Pre-Book The Orthopedic Biomaterials Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
How Are New Trends Impacting The Size Of The Orthopedic Biomaterials Market?
One of the latest trends in the orthopedic biomaterials market is the adoption of 3D printing for orthopedic implants. This advanced technology is used to manufacture an array of medical devices, including those with complex structures or attributes tailored to a specific patient's anatomy. The process of 3D printing orthopedic implants allows for the creation of more naturally shaped anatomical structures, as well as porous bone replacement scaffolds which can be seamlessly incorporated into the implant design. This aids in natural bone regeneration, thereby increasing the reliability of the implant. This trend in the orthopedic biomaterial market is drawing the attention of numerous players. Evonik, a chemical corporation based in Germany, is among those investing in this trend, having backed Meditool, a Chinese startup focused on 3D printed implants. Meditool uses polymers provided by Evonik to produce its models and implants.
Who Are the Key Players in the Orthopedic Biomaterials Market?
Major companies operating in the orthopedic biomaterials market include:
• Medtronic PLC
• Johnson & Johnson
• Stryker Corporation
• Zimmer Biomet
• Smith & Nephew
• NuVasive
• Wright Medical Group N.V.
• Orthofix Medical Inc.
• Acelity
• Conmed Corporation
• Aesculap
• Seaspine Holdings Corporation
• Bone Support AB
• Bioventus
• K2M Group Holdings. Inc.
• MTF Biologics
• Amedica Corporation
• TPL Biomed
• Fidia Farmaceutici S.p.A.
• OsteoRemedies
• Xtant Medical
• RTI Surgical Holdings. Inc.
• LifeNet Health
• VIVEX Biologics
• DJO Global
• MedShape
• Evonik Industries AG
• Heraeus Medical
• 3M Company
• Collagen Solutions plc
What are the Regional Insights into the Orthopedic Biomaterials Market?
North America was the largest region in the orthopedic biomaterials market in 2024. Western Europe was the second largest region in the orthopedic biomaterials market report. The regions covered in the orthopedic biomaterials market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
